In resected N2 NSCLC, what nodal pathologic characteristics prompt you to recommend PORT?

E.g., Multiple nodes (is there a minimum), ECE, LVSI? How do driver mutations, e.g., ALK, EGFR, affect your recommendation?

Answer from: Radiation Oncologist at Community Practice

Increasingly difficult question to answer with the evolution of neoadjuvant and adjuvant treatment paradigms. We know from both Lung ART and PORT-C that the addition of PORT in completely resected patients with N2 disease improves locoregional control across the cohort as a whole; however, this did ...

Comments

Radiation Oncologist at Beaumont Health System
In addition to the NCDB study, we also published a...

Please select the option that best describes you:

In resected N2 NSCLC, what nodal pathologic characteristics prompt you to recommend PORT?

Related Questions